- Home
- SRDX
SRDX
Surmodics Inc.
as 04-23-2025 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Surmodics Inc. SRDX prepares to release earnings report on 30 Apr 2025.
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | N/A | IPO Year: | 1998 |
| Target Price: | $43.00 | AVG Volume (30 days): | 88.9K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.17 - $42.44 | Next Earning Date: | 04-30-2025 |
| Revenue: | $125,448,000 | Revenue Growth: | -9.23% |
| Revenue Growth (this year): | 2.97% | Revenue Growth (next year): | 0.35% |
Latest Surmodics Inc. News
SRDX Breaking Stock News: Dive into SRDX Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
MedTech Dive
6 days ago
Illinois, Minnesota join FTC challenge against $627M Surmodics buyout
Zacks
19 days ago
SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System
Medical Device Network
20 days ago
Surmodics launches Pounce XL thrombectomy system
Business Wire
21 days ago
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries
Zacks
a month ago
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now
Medical Device Network
a month ago
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics
Zacks
2 months ago
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge
Compare SRDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRDX Surmodics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.